CFB
AGN

Cullen/Frost Bankers’s Allergan plc AGN Stock Holding History

Cullen/Frost Bankers’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,221
Closed -$216K – 1178
2020
Q1 		$216K Sell
1,221
-13
-1% -$2.45K 0.01% 352
2019
Q4 		$236K Sell
1,234
-1,082
-47% -$195K 0.01% 406
2019
Q3 		$390K Sell
2,316
-69
-3% -$11.2K 0.01% 335
2019
Q2 		$400K Buy
2,385
+4
+0.2% +$554 0.01% 331
2019
Q1 		$338K Buy
2,381
+128
+6% +$18.6K 0.01% 328
2018
Q4 		$301K Sell
2,253
-16
-0.7% -$2.62K 0.01% 330
2018
Q3 		$432K Sell
2,269
-288
-11% -$52.9K 0.01% 302
2018
Q2 		$427K Sell
2,557
-1,309
-34% -$210K 0.01% 307
2018
Q1 		$651K Sell
3,866
-511
-12% -$85.7K 0.02% 283
2017
Q4 		$716K Sell
4,377
-41,683
-90% -$7.48M 0.02% 267
2017
Q3 		$9.44M Buy
46,060
+3,081
+7% +$717K 0.31% 107
2017
Q2 		$10.4M Sell
42,979
-939
-2% -$221K 0.35% 102
2017
Q1 		$10.5M Sell
43,918
-6,401
-13% -$1.49M 0.36% 98
2016
Q4 		$10.6M Sell
50,319
-1,285
-2% -$266K 0.36% 94
2016
Q3 		$11.9M Buy
51,604
+4,748
+10% +$1.16M 0.43% 89
2016
Q2 		$10.8M Sell
46,856
-3,066
-6% -$707K 0.4% 89
2016
Q1 		$13.4M Buy
49,922
+1,886
+4% +$540K 0.5% 80
2015
Q4 		$15M Sell
48,036
-13,146
-21% -$3.91M 0.57% 71
2015
Q3 		$16.6M Buy
61,182
+2,090
+4% +$642K 0.66% 51
2015
Q2 		$17.9M Buy
59,092
+12,620
+27% +$3.76M 0.67% 47
2015
Q1 		$13.8M Buy
46,472
+20,587
+80% +$5.87M 0.52% 65
2014
Q4 		$6.66M Buy
+25,885
New +$6.47M 0.26% 119

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Cullen/Frost Bankers's AGN Position: Q2 2020 in Review

Cullen/Frost Bankers sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,221 shares — an estimated $216K sold.

Cullen/Frost Bankers first reported a position in AGN in Q4 2014 and held it in 22 quarters. The position peaked at $17.9M in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Cullen/Frost Bankers reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Cullen/Frost Bankers sold 1,221 Allergan plc shares in Q2 2020, an estimated $216K.
  • Cullen/Frost Bankers first reported a position in Allergan plc in Q4 2014 and held it in 22 quarters.
  • Cullen/Frost Bankers's Allergan plc position peaked at $17.9M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Cullen/Frost Bankers's 13F filing for Q2 2020, filed 5 Aug 2020.